Jenburkt Pharma

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE354A01013
NSEID:
BSEID: 524731
View on BSE

INR

1,140.90

-37.4 (-3.17%)

BSENSE

Jun 19, 03:30 PM

BSE+NSE Vol: 3.19 k

{
  "main_header": {
    "sid": 134395,
    "name": "Jenburkt Pharma",
    "stock_name": "Jenburkt Pharma",
    "full_name": "Jenburkt Pharmaceuticals Ltd.",
    "name_url": "stocks-analysis/jenburkt-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,140.90",
    "chg": -37.4,
    "chgp": "-3.17%",
    "dir": -1,
    "prev_price": "1,178.30",
    "mcapval": "517.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524731,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE354A01013",
    "curr_date": "Jun 19, 03:30 PM",
    "curr_time": "00:08 AM",
    "last_traded_at": "Jun 19, 03:30 PM IST",
    "bse_nse_vol": "3.19 k",
    "exc_status": "Active",
    "traded_date": "Jun 19, 2026",
    "traded_date_str": "2026 06 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/jenburkt-pharma-134395-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Jenburkt Pharmaceuticals Ltd. Technical Momentum Shifts Signal Cautious Optimism",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-ltd-technical-momentum-shifts-signal-cautious-optimism-4062536",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/JenburktPharmac_technicaldot_4062536.png",
        "date": "2026-06-19 08:00:09",
        "description": "Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Recent price action and technical indicators such as MACD, RSI, and moving averages reveal a complex but cautiously optimistic outlook for investors as the stock trades near ₹1,178.30, up 2.56% on the day."
      },
      {
        "title": "Jenburkt Pharmaceuticals Upgraded to Buy on Improved Technicals and Financial Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jenburkt-pharmaceuticals-upgraded-to-buy-on-improved-technicals-and-financial-metrics-4058071",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/JenburktPharmac_mojoScore_4058071.png",
        "date": "2026-06-17 08:01:31",
        "description": "Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Hold to Buy as of 16 June 2026. This upgrade reflects a combination of improved technical indicators, solid financial performance, and a favourable valuation outlook, signalling renewed investor confidence despite recent price volatility."
      },
      {
        "title": "Jenburkt Pharmaceuticals Ltd. Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-ltd-technical-momentum-shifts-signal-bullish-outlook-4057950",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/JenburktPharmac_technicaldot_4057950.png",
        "date": "2026-06-17 08:00:22",
        "description": "Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its technical momentum, upgrading its MarketsMOJO grade from Hold to Buy as of 16 June 2026. Despite a modest day decline of 1.50%, the stock’s technical indicators reveal a strengthening bullish trend, signalling potential opportunities for investors amid mixed broader market conditions."
      },
      {
        "title": "Jenburkt Pharmaceuticals Gains 4.37%: 2 Key Technical Shifts Drive Weekly Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-gains-437-2-key-technical-shifts-drive-weekly-momentum-4051675",
        "imagepath": "",
        "date": "2026-06-13 14:14:30",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>8 June:</strong> Stock rises 1.93% despite Sensex decline</p>\n                    <p><strong>10 June:</strong> Golden Cross formation signals bullish breakout</p>\n                    <p><strong>11 June:</strong> Mildly bullish momentum confirmed amid technical shifts</p>\n                    <p><strong>12 June:</strong> Strongest weekly gain of 2.57% closes week positively</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n                        <div class=\"stat-value\">Rs.1,137.70</div>\n                    </div>\n                    <div class=\"stat-item\">\n ..."
      },
      {
        "title": "Jenburkt Pharmaceuticals Ltd. Exhibits Mildly Bullish Momentum Amid Technical Parameter Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-ltd-exhibits-mildly-bullish-momentum-amid-technical-parameter-shift-4045685",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/JenburktPharmac_technicaldot_4045685.png",
        "date": "2026-06-11 08:00:20",
        "description": "Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by a series of mixed but predominantly positive technical indicator signals, prompting an upgrade in its Mojo Grade from Sell to Hold as of 3 February 2026."
      },
      {
        "title": "Golden Cross Confirmed: Do Jenburkt Pharmaceuticals Ltd.'s Other Technical Indicators Agree?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-ltd-forms-golden-cross-signalling-potential-bullish-breakout-4044688",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/JenburktPharmac_goldencross_4044688.png",
        "date": "2026-06-10 18:00:20",
        "description": "The 50-day moving average has crossed above the 200-day moving average for Jenburkt Pharmaceuticals Ltd., signalling a golden cross on 10 Jun 2026. Yet, the broader technical picture is nuanced, with weekly indicators largely supportive but monthly momentum showing mild bearishness. This divergence invites a closer look at whether the crossover is a reliable signal or a lone beacon amid mixed data."
      },
      {
        "title": "Jenburkt Pharmaceuticals Ltd. is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jenburkt-pharmaceuticals-ltd-is-rated-hold-4041052",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/JenburktPharmac_mojoScore_4041052.png",
        "date": "2026-06-09 10:10:03",
        "description": "Jenburkt Pharmaceuticals Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 09 June 2026, providing investors with the most up-to-date view of the company’s fundamentals and market performance."
      },
      {
        "title": "Jenburkt Pharmaceuticals Ltd. Technical Momentum Shifts Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicators-4029023",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/JenburktPharmac_technicaldot_4029023.png",
        "date": "2026-06-02 08:00:30",
        "description": "Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. This transition is underscored by a complex interplay of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, which collectively paint a nuanced picture of the stock’s near-term prospects."
      },
      {
        "title": "Jenburkt Pharmaceuticals Ltd. is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jenburkt-pharmaceuticals-ltd-is-rated-hold-4013572",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JenburktPharmac_mojoScore_4013572.png",
        "date": "2026-05-26 10:10:03",
        "description": "Jenburkt Pharmaceuticals Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 26 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      }
    ],
    "total": 520,
    "sid": "134395",
    "stock_news_url": "https://www.marketsmojo.com/news/jenburkt-pharmaceuticals-134395"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "18-Jun-2026",
      "details": "Intimation of Closure of Trading Window of Jenburkt Pharmaceuticals Limited as per SEBI(Prohibition of Insider Trading) Regulations 2015.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "27-May-2026",
      "details": "Newspaper Advertisement for giving notice for the purpose of transfer of unclaimed dividend and corresponding equity shares of the Company to IEPFA.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "07-May-2026",
      "details": "Annual Secretraial Compliance Report for the financial year ended 31st March 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Jenburkt Pharmaceuticals Ltd. has declared <strong>180%</strong> dividend, ex-date: 11 Jul 25",
          "dt": "2025-07-11",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Jenburkt Pharmaceuticals Ltd. Technical Momentum Shifts Signal Cautious Optimism

2026-06-19 08:00:09

Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Recent price action and technical indicators such as MACD, RSI, and moving averages reveal a complex but cautiously optimistic outlook for investors as the stock trades near ₹1,178.30, up 2.56% on the day.

Read full news article

Jenburkt Pharmaceuticals Upgraded to Buy on Improved Technicals and Financial Metrics

2026-06-17 08:01:31

Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Hold to Buy as of 16 June 2026. This upgrade reflects a combination of improved technical indicators, solid financial performance, and a favourable valuation outlook, signalling renewed investor confidence despite recent price volatility.

Read full news article

Jenburkt Pharmaceuticals Ltd. Technical Momentum Shifts Signal Bullish Outlook

2026-06-17 08:00:22

Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its technical momentum, upgrading its MarketsMOJO grade from Hold to Buy as of 16 June 2026. Despite a modest day decline of 1.50%, the stock’s technical indicators reveal a strengthening bullish trend, signalling potential opportunities for investors amid mixed broader market conditions.

Read full news article

Jenburkt Pharmaceuticals Gains 4.37%: 2 Key Technical Shifts Drive Weekly Momentum

2026-06-13 14:14:30

Key Events This Week

8 June: Stock rises 1.93% despite Sensex decline

10 June: Golden Cross formation signals bullish breakout

11 June: Mildly bullish momentum confirmed amid technical shifts

12 June: Strongest weekly gain of 2.57% closes week positively

Week Open

Rs.1,137.70

...

Read full news article

Jenburkt Pharmaceuticals Ltd. Exhibits Mildly Bullish Momentum Amid Technical Parameter Shift

2026-06-11 08:00:20

Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by a series of mixed but predominantly positive technical indicator signals, prompting an upgrade in its Mojo Grade from Sell to Hold as of 3 February 2026.

Read full news article

Golden Cross Confirmed: Do Jenburkt Pharmaceuticals Ltd.'s Other Technical Indicators Agree?

2026-06-10 18:00:20

The 50-day moving average has crossed above the 200-day moving average for Jenburkt Pharmaceuticals Ltd., signalling a golden cross on 10 Jun 2026. Yet, the broader technical picture is nuanced, with weekly indicators largely supportive but monthly momentum showing mild bearishness. This divergence invites a closer look at whether the crossover is a reliable signal or a lone beacon amid mixed data.

Read full news article

Jenburkt Pharmaceuticals Ltd. is Rated Hold

2026-06-09 10:10:03

Jenburkt Pharmaceuticals Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 09 June 2026, providing investors with the most up-to-date view of the company’s fundamentals and market performance.

Read full news article

Jenburkt Pharmaceuticals Ltd. Technical Momentum Shifts Amid Mixed Indicators

2026-06-02 08:00:30

Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. This transition is underscored by a complex interplay of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, which collectively paint a nuanced picture of the stock’s near-term prospects.

Read full news article

Jenburkt Pharmaceuticals Ltd. is Rated Hold

2026-05-26 10:10:03

Jenburkt Pharmaceuticals Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 May 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 26 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.